Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/1488
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
dc.contributor.author | KLOMP, Margo | - |
dc.contributor.author | DAMMAN, Peter | - |
dc.contributor.author | BEIJK, Marcel A. M. | - |
dc.contributor.author | SILBER, Sigmund | - |
dc.contributor.author | GRISOLD, Manfred | - |
dc.contributor.author | RIBEIRO, Expedito E. | - |
dc.contributor.author | SURYAPRANATA, Harry | - |
dc.contributor.author | WOJCIK, Jaroslaw | - |
dc.contributor.author | SIM, Kui Hian | - |
dc.contributor.author | TIJSSEN, Jan G. P. | - |
dc.contributor.author | WINTER, Robbert J. de | - |
dc.date.accessioned | 2013-07-30T17:52:33Z | - |
dc.date.available | 2013-07-30T17:52:33Z | - |
dc.date.issued | 2012 | - |
dc.identifier.citation | HEART AND VESSELS, v.27, n.4, p.360-369, 2012 | - |
dc.identifier.issn | 0910-8327 | - |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/1488 | - |
dc.description.abstract | The National Institute for Clinical Excellence (NICE) guidelines recommend the use of bare-metal stents (BMS) in non-complex lesions with a low risk of restenosis (diameter a parts per thousand yen3 mm and lesion length a parts per thousand currency sign15 mm) and the use of drug-eluting stents (DES) in more complex lesions with a high risk of restenosis (diameter < 3.0 mm or lesion length > 15 mm). However, the guidelines were created based on studies evaluating BMS and DES only. We performed an analysis of patients undergoing non-urgent percutaneous coronary intervention with the novel endothelial cell capturing stent (ECS). The ECS is coated with CD34(+) antibodies that attract circulating endothelial progenitor cells to the stent surface, thereby accelerating the endothelialization of the stented area. We analyzed all patients enrolled in the worldwide e-HEALING registry that met the NICE criteria for either low-risk or high-risk lesions and were treated with a parts per thousand yen1 ECS. The main study outcome was target vessel failure (TVF) at 12-month follow-up, defined as the composite of cardiac death or MI and target vessel revascularization (TVR). A total of 4,241 patients were assessed in the current analysis. At 12-month follow-up, TVF occurred in 7.0% of the patients with low-risk lesions and in 8.8% of the patients with high-risk lesions (p = 0.045). When evaluating the diabetic patients versus the non-diabetic patients per risk group, no significant differences were found in TVF, MI or TVR in either risk group. The ECS shows good clinical outcomes in lesions carrying either a high or a low risk of restenosis according to the NICE guidelines with comparable rates of cardiac death, myocardial infarction, and stent thrombosis. The TVF rate with ECS was slightly higher in patients with high-risk lesions, driven by higher clinically driven TLR. The risk of restenosis with ECS in patients carrying high-risk lesions needs to be carefully considered relative to other risks associated with DES. Furthermore, the presence of diabetes mellitus did not influence the incidence of TVF in either risk group. | - |
dc.description.sponsorship | OrbusNeich Medical BV | - |
dc.description.sponsorship | OrbusNeich Medical BV, The Netherlands | - |
dc.language.iso | eng | - |
dc.publisher | SPRINGER | - |
dc.relation.ispartof | Heart and Vessels | - |
dc.rights | restrictedAccess | - |
dc.subject | National Institute for Clinical Excellence | - |
dc.subject | Endothelial progenitor cells | - |
dc.subject | Restenosis | - |
dc.subject.other | percutaneous coronary intervention | - |
dc.subject.other | sirolimus-eluting stent | - |
dc.subject.other | cell capturing stent | - |
dc.subject.other | taxus liberte stent | - |
dc.subject.other | diabetes-mellitus | - |
dc.subject.other | single-center | - |
dc.subject.other | slow-release | - |
dc.subject.other | high-risk | - |
dc.subject.other | artery lesions | - |
dc.subject.other | placement | - |
dc.title | Applying the National Institute for Clinical Excellence criteria to patients treated with the Genous (TM) Bio-engineered R stent (TM): a sub-study of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry | - |
dc.type | article | - |
dc.rights.holder | Copyright SPRINGER | - |
dc.identifier.doi | 10.1007/s00380-011-0167-8 | - |
dc.identifier.pmid | 21725668 | - |
dc.subject.wos | Cardiac & Cardiovascular Systems | - |
dc.subject.wos | Peripheral Vascular Disease | - |
dc.type.category | original article | - |
dc.type.version | publishedVersion | - |
hcfmusp.author.external | KLOMP, Margo:Univ Amsterdam, Dept Cardiol, Cardiac Catheterizat Lab, Acad Med Ctr B2 137, NL-1105 AZ Amsterdam, Netherlands | - |
hcfmusp.author.external | DAMMAN, Peter:Univ Amsterdam, Dept Cardiol, Cardiac Catheterizat Lab, Acad Med Ctr B2 137, NL-1105 AZ Amsterdam, Netherlands | - |
hcfmusp.author.external | BEIJK, Marcel A. M.:Univ Amsterdam, Dept Cardiol, Cardiac Catheterizat Lab, Acad Med Ctr B2 137, NL-1105 AZ Amsterdam, Netherlands | - |
hcfmusp.author.external | SILBER, Sigmund:Kardiol Praxis & Praxisklin, Munich, Germany | - |
hcfmusp.author.external | GRISOLD, Manfred:Med Univ Klin, Klin Abt Kardiol, Graz, Austria | - |
hcfmusp.author.external | SURYAPRANATA, Harry:Hosp Weezenlanden, Isala Klinieken, Zwolle, Netherlands | - |
hcfmusp.author.external | WOJCIK, Jaroslaw:Med Univ Lublin, Dept Cardiol, Lublin, Poland | - |
hcfmusp.author.external | SIM, Kui Hian:Sarawak Gen Hosp, Kuching, Sarawak, Malaysia | - |
hcfmusp.author.external | TIJSSEN, Jan G. P.:Univ Amsterdam, Dept Cardiol, Cardiac Catheterizat Lab, Acad Med Ctr B2 137, NL-1105 AZ Amsterdam, Netherlands | - |
hcfmusp.author.external | WINTER, Robbert J. de:Univ Amsterdam, Dept Cardiol, Cardiac Catheterizat Lab, Acad Med Ctr B2 137, NL-1105 AZ Amsterdam, Netherlands | - |
hcfmusp.description.beginpage | 360 | - |
hcfmusp.description.endpage | 369 | - |
hcfmusp.description.issue | 4 | - |
hcfmusp.description.volume | 27 | - |
hcfmusp.origem | WOS | - |
hcfmusp.origem.id | 2-s2.0-84864278152 | - |
hcfmusp.origem.id | WOS:000306428000004 | - |
hcfmusp.publisher.city | NEW YORK | - |
hcfmusp.publisher.country | USA | - |
hcfmusp.relation.reference | Abizaid A, 1998, J AM COLL CARDIOL, V32, P584, DOI 10.1016/S0735-1097(98)00286-1 | - |
hcfmusp.relation.reference | Aoki J, 2005, J AM COLL CARDIOL, V45, P1574, DOI 10.1016/j.jacc.2005.01.048 | - |
hcfmusp.relation.reference | Beijk MAM, 2011, CATHETER CARDIO INTE, V78, P189, DOI 10.1002/ccd.23143 | - |
hcfmusp.relation.reference | Beijk MAM, 2010, EUR HEART J, V31, P1055, DOI 10.1093/eurheartj/ehp476 | - |
hcfmusp.relation.reference | Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6 | - |
hcfmusp.relation.reference | Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313 | - |
hcfmusp.relation.reference | Duckers Henricus J, 2007, EuroIntervention, V3, P350, DOI 10.4244/EIJV3I3A64 | - |
hcfmusp.relation.reference | Duckers Henricus J, 2007, EuroIntervention, V3, P67 | - |
hcfmusp.relation.reference | Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179 | - |
hcfmusp.relation.reference | Elezi S, 1998, CIRCULATION, V98, P1875 | - |
hcfmusp.relation.reference | Elezi S, 1998, J AM COLL CARDIOL, V32, P1866, DOI 10.1016/S0735-1097(98)00467-7 | - |
hcfmusp.relation.reference | Ellis SG, 2004, CATHETER CARDIO INTE, V63, P135, DOI 10.1002/ccd.20132 | - |
hcfmusp.relation.reference | Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739 | - |
hcfmusp.relation.reference | Grines CL, 2007, J AM DENT ASSOC, V138, P652 | - |
hcfmusp.relation.reference | Grube E, 2003, CIRCULATION, V107, P38, DOI 10.1161/01.CIR.0000047700.58683.A1 | - |
hcfmusp.relation.reference | Hofma SH, 2006, EUR HEART J, V27, P166, DOI 10.1093/eurheartj/ehi571 | - |
hcfmusp.relation.reference | Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042 | - |
hcfmusp.relation.reference | Kastrati A, 1999, AM J CARDIOL, V83, P1617, DOI 10.1016/S0002-9149(99)00165-4 | - |
hcfmusp.relation.reference | Klomp M, 2010, TCT 2010 CONV WASH U | - |
hcfmusp.relation.reference | Klomp M, 2009, AM HEART J, V158, P527, DOI 10.1016/j.ahj.2009.07.022 | - |
hcfmusp.relation.reference | Klomp M, 2011, CATHETER CARDIO INTE, V77, P809, DOI 10.1002/ccd.22795 | - |
hcfmusp.relation.reference | Kutryk MJB, 2003, AM J CARDIOL, V92, p94L | - |
hcfmusp.relation.reference | Kutryk MJ, 2003, CIRCULATION, V108, P573 | - |
hcfmusp.relation.reference | Kutryk MJ, 2004, INT S END THER, P125 | - |
hcfmusp.relation.reference | Miglionico M, 2008, CATHETER CARDIO INTE, V71, P600, DOI 10.1002/ccd.21437 | - |
hcfmusp.relation.reference | Miyai N, 2011, HEART VESSELS, V26, P168, DOI 10.1007/s00380-010-0043-y | - |
hcfmusp.relation.reference | Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843 | - |
hcfmusp.relation.reference | National Institute for Health and Clinical Excellence, 2010, NICE TECHN APPR TA15 | - |
hcfmusp.relation.reference | Ndrepepa G, 2010, HEART VESSELS, V25, P294, DOI 10.1007/s00380-009-1205-7 | - |
hcfmusp.relation.reference | Ong ATL, 2005, J AM COLL CARDIOL, V45, P2088, DOI 10.1016/j.jacc.2005.02.086 | - |
hcfmusp.relation.reference | Schofer J, 2000, J AM COLL CARDIOL, V35, P1554, DOI 10.1016/S0735-1097(00)00574-X | - |
hcfmusp.relation.reference | Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138 | - |
hcfmusp.relation.reference | Silber S, 2011, EUROINTERVENTION, V6, P819, DOI 10.4244/EIJV6I7A141 | - |
hcfmusp.relation.reference | Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066 | - |
hcfmusp.relation.reference | STEIN B, 1995, CIRCULATION, V91, P979 | - |
hcfmusp.relation.reference | Stone GW, 2004, CIRCULATION, V109, P1942, DOI 10.1161/01.CIR.0000127110.49192.72 | - |
dc.description.index | MEDLINE | - |
hcfmusp.citation.scopus | 8 | - |
hcfmusp.scopus.lastupdate | 2024-04-12 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - HC/InCor |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_RIBEIRO_Applying_the_National_Institute_for_Clinical_Excellence_criteria_2012.PDF Restricted Access | publishedVersion (English) | 288.86 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.